Perkins Coie’s Chicago Office Adds Three More IP Attorneys

Perkins Coie is pleased to announce that Michael R. Osterhoff, Adam L. Marchuk and Heather A. Boice have joined the firm’s patent litigation practice in Chicago. All three attorneys were most recently partners at K&L Gates LLP. The arrival of Osterhoff, Marchuk and Boice follows closely upon the recent addition of Dave Fournier to the firm’s Chicago office.

More >>

Tags:  Perkins Coie LLP

Simpson Thacher Represents Pinnacle Foods in $667 Million Initial Public Offering

The Firm recently represented Pinnacle Foods Inc. (“Pinnacle Foods”), a portfolio company of The Blackstone Group, L.P., in connection with its initial public offering of common stock. The offering of 33,350,000 shares of common stock, which included the underwriters’ option to purchase 4,350,000 additional shares, raised approximately $667 million in gross proceeds. The shares of Pinnacle Foods are now listed on The New York Stock Exchange under the ticker symbol “PF.”

More >>

Tags:  Simpson Thacher & Bartlett LLP | New York

Kirkland & Ellis LLP Represents Arsenal Capital Partners in Final Closing of $875 Million Fund III

Kirkland & Ellis LLP represented Arsenal Capital Partners, a leading private equity firm that invests in lower middle-market specialty industrial and health care companies, which today announced it completed fundraising for Arsenal Capital Fund III, L.P. The fund was oversubscribed with $875 million of committed capital and exceeded its original target of $750 million. Fund III’s investor base is international in scope, with institutional investors from the United States, Europe and Asia, and consists primarily of endowments and foundations, public and corporate pension plans, diversified financial institutions and family offices.

More >>

Tags:  Kirkland & Ellis LLP

Dickstein Shapiro Deepens Biotech Prosecution Bench; Welcomes Dr. Atulya R. Agarwal, Elan’s Former Chief IP Officer

Dickstein Shapiro LLP is pleased to announce that Atulya R. Agarwal has joined the firm’s Intellectual Property Practice as partner, effective April 1, in its Palo Alto, California office. He joins the firm from Elan Pharmaceuticals, Inc. where he was a senior vice president and served as Elan’s chief intellectual property officer. Dr. Agarwal has more than two decades of life-sciences experience, including 10-plus years as in-house IP counsel to biopharmaceutical companies. His arrival strengthens the firm’s biotechnology patent prosecution, strategy, and licensing practices in Palo Alto, and his practice will leverage his extensive industry and in-house experience to assist companies in developing IP strategies to maximize the value of their portfolios by protecting assets and products though patent counseling, prosecution, due diligence, transactions, and litigation.

More >>

Tags:   | Silicon Valley